28280642|t|Severe Preeclampsia in the Setting of Myasthenia Gravis
28280642|a|Myasthenia gravis (MG) is a rare autoimmune disease that leads to progressive muscle weakness and is common during female reproductive years. The myasthenic mother and her newborn must be observed carefully, as complications during all stages of pregnancy and the puerperium may arise suddenly. Preeclampsia is a common obstetrical condition for which magnesium sulfate is used for seizure prophylaxis. However, magnesium sulfate is strongly contraindicated in MG as it impairs already slowed nerve - muscle connections. Similarly, many first-line antihypertensive medications, including calcium channels blockers and Î²-blockers, may lead to MG exacerbation. This case describes the effective obstetrical management of a patient with MG who developed severe preeclampsia. The effective use of levetiracetam and various antihypertensive medications including intravenous labetalol is described. A review of the ten reported cases of MG complicated by preeclampsia is examined to aggregate observations of clinical care, with focus on delivery methods, anticonvulsants, and antihypertensive medications.
28280642	0	19	Severe Preeclampsia	T038	UMLS:C0341950
28280642	38	55	Myasthenia Gravis	T038	UMLS:C0026896
28280642	56	73	Myasthenia gravis	T038	UMLS:C0026896
28280642	75	77	MG	T038	UMLS:C0026896
28280642	89	107	autoimmune disease	T038	UMLS:C0004364
28280642	134	149	muscle weakness	T033	UMLS:C0151786
28280642	178	190	reproductive	T038	UMLS:C0035150
28280642	202	212	myasthenic	T038	UMLS:C0026896
28280642	267	280	complications	T038	UMLS:C0009566
28280642	302	311	pregnancy	T038	UMLS:C0032961
28280642	351	363	Preeclampsia	T038	UMLS:C0032914
28280642	408	425	magnesium sulfate	T103	UMLS:C0024480
28280642	438	445	seizure	T033	UMLS:C0036572
28280642	446	457	prophylaxis	T058	UMLS:C0199176
28280642	468	485	magnesium sulfate	T103	UMLS:C0024480
28280642	498	513	contraindicated	T033	UMLS:C1444657
28280642	517	519	MG	T038	UMLS:C0026896
28280642	549	554	nerve	T017	UMLS:C0027740
28280642	557	563	muscle	T017	UMLS:C0026845
28280642	564	575	connections	T017	UMLS:C0086699
28280642	593	603	first-line	T058	UMLS:C1708063
28280642	604	632	antihypertensive medications	T058	UMLS:C0585941
28280642	698	700	MG	T038	UMLS:C0026896
28280642	701	713	exacerbation	T033	UMLS:C4086268
28280642	790	792	MG	T038	UMLS:C0026896
28280642	807	826	severe preeclampsia	T038	UMLS:C0341950
28280642	849	862	levetiracetam	T103	UMLS:C0377265
28280642	875	903	antihypertensive medications	T058	UMLS:C0585941
28280642	914	925	intravenous	T082	UMLS:C0348016
28280642	926	935	labetalol	T103	UMLS:C0022860
28280642	988	990	MG	T038	UMLS:C0026896
28280642	1006	1018	preeclampsia	T038	UMLS:C0032914
28280642	1022	1030	examined	T033	UMLS:C0420616
28280642	1089	1105	delivery methods	T058	UMLS:C0565867
28280642	1107	1122	anticonvulsants	T103	UMLS:C0003286
28280642	1128	1156	antihypertensive medications	T058	UMLS:C0585941